Loading chat...
HI SCR8
Concurrent Resolution
Status
3/31/2025
Primary Sponsor
Kurt Fevella
Click for details
AI Summary
-
Request the State Auditor to assess the social and financial effects of S.B. No. 967 (Regular Session of 2025), which proposes mandated health insurance coverage for intravenous ketamine therapy to treat depression.
-
Require the Auditor to evaluate various percentage levels of cost coverage for intravenous ketamine therapy in qualifying patients.
-
Mandate the Auditor submit findings, recommendations, and any proposed legislation to the Legislature no later than twenty days before the Regular Session of 2026 convenes.
-
Transmit certified copies of the resolution to the State Auditor and Insurance Commissioner.
-
Comply with Hawaii Revised Statutes section 23-51, which requires concurrent resolution approval and auditor assessment before considering mandated health insurance coverage legislation.
Legislative Description
Requesting The Auditor To Assess Both The Social And Financial Effects Of Proposed Mandated Health Insurance Coverage For A Percentage Of The Costs Of Intravenous Ketamine Therapy To Treat Depression.
Medicaid
Last Action
Report adopted; referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and none excused (0).
4/14/2025